Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients.
HCV
HCV/HPgV-2 coinfection
HPgV-2
cytokine
intrahost variants
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
06
2021
accepted:
26
07
2021
entrez:
1
9
2021
pubmed:
2
9
2021
medline:
21
10
2021
Statut:
epublish
Résumé
The second human pegivirus (HPgV-2) and hepatitis C virus (HCV) belong to the Flaviviridae family and share some common genome features. However, the two viruses exhibit significantly different genetic diversity. The comparison of intrahost dynamics of HPgV-2 and HCV that mainly reflect virus-host interactions is needed to elucidate their intrahost difference of genetic diversity and the possible mechanisms. Intrahost single nucleotide variations (iSNVs) were identified by means of next-generation sequencing from both cross-sectional and longitudinal samples from HPgV-2- and HCV-coinfected patients. The levels of human cytokines were quantified in the patient before and after HCV elimination by the treatment of direct-acting antivirals (DAA). Unlike HCV, the viral sequences of HPgV-2 are highly conserved among HPgV-2-infected patients. However, iSNV analysis confirmed the intrahost variation or quasispecies of HPgV-2. Almost all iSNVs of HPgV-2 did not accumulate or transmit within host over time, which may explain the highly conserved HPgV-2 consensus sequence. Intrahost variation of HPgV-2 mainly causes nucleotide transition in particular at the 3rd codon position and synonymous substitutions, indicating purifying or negative selection posed by host immune system. Cytokine data further indicate that HPgV-2 infection alone may not efficiently stimulate innate immune responses since proinflammatory cytokine expression dramatically decreased with elimination of HCV. This study provided new insights into the intrahost genomic variations and evolutionary dynamics of HPgV-2 as well as the impact of host immune selection and virus polymerase on virus evolution. The different genetic diversity of HPgV-2 and HCV makes HPgV-2 a potential new model to investigate RNA virus diversity and the mechanism of viral polymerase in modulating virus replication.
Sections du résumé
Background
The second human pegivirus (HPgV-2) and hepatitis C virus (HCV) belong to the Flaviviridae family and share some common genome features. However, the two viruses exhibit significantly different genetic diversity. The comparison of intrahost dynamics of HPgV-2 and HCV that mainly reflect virus-host interactions is needed to elucidate their intrahost difference of genetic diversity and the possible mechanisms.
Methods
Intrahost single nucleotide variations (iSNVs) were identified by means of next-generation sequencing from both cross-sectional and longitudinal samples from HPgV-2- and HCV-coinfected patients. The levels of human cytokines were quantified in the patient before and after HCV elimination by the treatment of direct-acting antivirals (DAA).
Results
Unlike HCV, the viral sequences of HPgV-2 are highly conserved among HPgV-2-infected patients. However, iSNV analysis confirmed the intrahost variation or quasispecies of HPgV-2. Almost all iSNVs of HPgV-2 did not accumulate or transmit within host over time, which may explain the highly conserved HPgV-2 consensus sequence. Intrahost variation of HPgV-2 mainly causes nucleotide transition in particular at the 3rd codon position and synonymous substitutions, indicating purifying or negative selection posed by host immune system. Cytokine data further indicate that HPgV-2 infection alone may not efficiently stimulate innate immune responses since proinflammatory cytokine expression dramatically decreased with elimination of HCV.
Conclusion
This study provided new insights into the intrahost genomic variations and evolutionary dynamics of HPgV-2 as well as the impact of host immune selection and virus polymerase on virus evolution. The different genetic diversity of HPgV-2 and HCV makes HPgV-2 a potential new model to investigate RNA virus diversity and the mechanism of viral polymerase in modulating virus replication.
Identifiants
pubmed: 34466405
doi: 10.3389/fcimb.2021.728415
pmc: PMC8403064
doi:
Substances chimiques
Antiviral Agents
0
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
728415Informations de copyright
Copyright © 2021 Liang, Hu, Fan, Li, Wan, Wang, Shui, Zhou, Tong, Cai and Tang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMC Genomics. 2013;14 Suppl 1:S7
pubmed: 23368723
Emerg Infect Dis. 2016 Apr;22(4):671-8
pubmed: 26982117
Bioinformatics. 2009 Jun 1;25(11):1451-2
pubmed: 19346325
Nat Rev Microbiol. 2007 Jun;5(6):453-63
pubmed: 17487147
PLoS One. 2007 May 30;2(5):e484
pubmed: 17534434
PLoS Curr. 2015 Feb 09;7:
pubmed: 25737802
Nucleic Acids Res. 2015 Mar 31;43(6):e37
pubmed: 25586220
Emerg Infect Dis. 2018 May;24(5):908-911
pubmed: 29664364
Nucleic Acids Res. 2018 Nov 16;46(20):10840-10854
pubmed: 30239956
J Gen Virol. 2005 Jul;86(Pt 7):1931-1942
pubmed: 15958671
Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Clin Infect Dis. 2018 Jan 6;66(1):29-35
pubmed: 29020289
J Med Virol. 1998 Apr;54(4):256-64
pubmed: 9557291
Sci Rep. 2018 Mar 22;8(1):5036
pubmed: 29568043
J Viral Hepat. 2019 Jan;26(1):30-37
pubmed: 30187640
Nat Genet. 2010 Nov;42(11):969-72
pubmed: 20890277
Nature. 2006 Jan 19;439(7074):344-8
pubmed: 16327776
Cell. 2015 Jun 18;161(7):1516-26
pubmed: 26091036
Clin Infect Dis. 2020 Jul 28;71(15):713-720
pubmed: 32129843
J Clin Microbiol. 2016 Aug;54(8):2023-30
pubmed: 27225404
mBio. 2015 Sep 22;6(5):e01466-15
pubmed: 26396247
Hepatology. 1998 Jun;27(6):1678-86
pubmed: 9620342
Open Forum Infect Dis. 2019 Jul 12;6(8):ofz329
pubmed: 31660385
Hepatology. 2014 Jan;59(1):318-27
pubmed: 24115039
PLoS Genet. 2008 May 30;4(5):e1000083
pubmed: 18516229
Emerg Microbes Infect. 2020 Dec;9(1):485-495
pubmed: 32100631
J Infect Dis. 2016 Jun 15;213(12):1897-905
pubmed: 26908731
Nature. 2014 Jan 30;505(7485):686-90
pubmed: 24284629
Virology. 2020 Jan 2;539:69-79
pubmed: 31689572
PLoS Negl Trop Dis. 2018 Sep 6;12(9):e0006738
pubmed: 30188905
J Virol. 2011 Jul;85(13):6369-80
pubmed: 21525348
Emerg Infect Dis. 2018 Nov;24(11):2063-2067
pubmed: 30334714
PLoS Pathog. 2015 Dec 11;11(12):e1005325
pubmed: 26658760
Ann Intern Med. 2018 Jan 16;168(2):158-159
pubmed: 29335729
Gene. 1992 Dec 15;122(2):281-8
pubmed: 1336756
Mol Ecol. 2020 Sep;29(17):3361-3379
pubmed: 32390272
PLoS One. 2017 Oct 17;12(10):e0186213
pubmed: 29040318